Skip to main content

Sage Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET to review third quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.26
+1.01 (0.44%)
AAPL  269.81
+0.81 (0.30%)
AMD  260.44
+2.44 (0.94%)
BAC  52.78
-0.09 (-0.16%)
GOOG  272.89
+4.46 (1.66%)
META  749.20
-2.24 (-0.30%)
MSFT  538.53
-3.54 (-0.65%)
NVDA  206.70
+5.67 (2.82%)
ORCL  276.13
-4.69 (-1.67%)
TSLA  459.07
-1.48 (-0.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.